Zimbabwe has declined a major American healthcare agreement valued at 367 million US dollars (£272m) over five years over Washington's request for sensitive information.
This rejection became public following a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesman has since stated that the US was seeking genetic material for scientific study and profit but refused to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further negotiations to find a agreement agreeable to both sides so the country's critical HIV programme can proceed.
Wider Background
This development comes after a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US after legal challenges were raised about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.
According to reports, 16 African countries have to date agreed to these new agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment through American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, without any equivalent guarantee of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our country would supply the basic resources for medical research with no assurance that the end products would be available to our citizens if a new pandemic emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending frameworks previously established through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with future global health emergencies.
"This framework is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to ongoing dialogue with our American counterparts on how future co-operation could be structured in a manner that honours the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but urged that talks need to persist considering a large portion of the country's HIV programmes depended on international support.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group commented.
This impasse highlights the ongoing tensions between accepting much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.